Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kerger

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Chemotherapy|July 25, 2013
Potential interactions with anticancer agents: a cross-sectional studyA Mouzon, J Kerger, L D'Hondt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Systemic treatment for locally advanced breast cancer: what we still need to learn after a decade of multimodality clinical trialsM J Piccart, J Kerger, E Tomiak, et al.
British Journal of Cancer|November 21, 1998
Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patientsR de Wit, W H Kruit, G Stoter, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 10, 1997
Mitomycin C and vinblastine in combination with amifostine in metastatic breast cancer. A feasibility study of the EORTC--Investigational Drug Branch for Breast Cancer (IDBBC)Z Kusenda, J Kerger, A Awada, et al.
Lancet (London, England)|December 3, 1994
Tumour stimulating effects of recombinant human interleukin-6C Ravoet, J DeGrève, K Vandewoude, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials GroupS Aamdal, I Wolff, S Kaplan, et al.
Journal of Visceral Surgery|December 16, 2019
A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancerG Liberale, C-F Pop, L Polastro, et al.
Facts, Views & Vision in Obgyn|October 30, 2020
Treatment algorithm in patients with ovarian cancerI Vergote, H Denys, J De Greve, et al.
Transplantation Proceedings|April 1, 1995
Inadvertent transfer of choriocarcinoma with renal transplantation: characteristics of the donor-recipient pairsJ M Doutrelepont, O Mat, D Abramowicz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicityS Aamdal, U Bruntsch, J Kerger, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Chemotherapy|July 25, 2013
Potential interactions with anticancer agents: a cross-sectional studyA Mouzon, J Kerger, L D'Hondt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Systemic treatment for locally advanced breast cancer: what we still need to learn after a decade of multimodality clinical trialsM J Piccart, J Kerger, E Tomiak, et al.
British Journal of Cancer|November 21, 1998
Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patientsR de Wit, W H Kruit, G Stoter, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 10, 1997
Mitomycin C and vinblastine in combination with amifostine in metastatic breast cancer. A feasibility study of the EORTC--Investigational Drug Branch for Breast Cancer (IDBBC)Z Kusenda, J Kerger, A Awada, et al.
Lancet (London, England)|December 3, 1994
Tumour stimulating effects of recombinant human interleukin-6C Ravoet, J DeGrève, K Vandewoude, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials GroupS Aamdal, I Wolff, S Kaplan, et al.
Journal of Visceral Surgery|December 16, 2019
A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancerG Liberale, C-F Pop, L Polastro, et al.
Facts, Views & Vision in Obgyn|October 30, 2020
Treatment algorithm in patients with ovarian cancerI Vergote, H Denys, J De Greve, et al.
Transplantation Proceedings|April 1, 1995
Inadvertent transfer of choriocarcinoma with renal transplantation: characteristics of the donor-recipient pairsJ M Doutrelepont, O Mat, D Abramowicz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicityS Aamdal, U Bruntsch, J Kerger, et al.
Pageof 3